BVXV Projected Dividend Yield
Scinai Immunotherapeutics Ltd ( NASDAQ : BVXV )BiondVax Pharmaceuticals is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and related illnesses. Co. has developed M-001, a flu vaccine candidate that was designed to provide multi-strain and multi-season protection against existing and future, seasonal and pandemic influenza. M-001 is intended to be intramuscularly injected into the body. Once administered, M-001 is designed to be recognized by the immune system, triggering both humoral and cellular immune reactions. 20 YEAR PERFORMANCE RESULTS |
BVXV Dividend History Detail BVXV Dividend News BVXV Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |